QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-trevena-maintains-9-price-target

HC Wainwright & Co. analyst Douglas Tsao maintains Trevena (NASDAQ:TRVN) with a Buy and maintains $9 price target.

 recap-trevena-q4-earnings
Recap: Trevena Q4 Earnings
04/01/2024 13:40:13

 trevena-q4-eps-106-misses-038-estimate-cash-balance-of-33m

Trevena (NASDAQ:TRVN) reported quarterly losses of $(1.06) per share which missed the analyst consensus estimate of $(0.38) by ...

 hc-wainwright--co-reiterates-buy-on-trevena-maintains-9-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Trevena (NASDAQ:TRVN) with a Buy and maintains $9 price target.

 trevena-granted-us-patent-11912693-titled-compounds-for-modulating-s1p1-activity-and-methods-of-using-the-same

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11912693

 trevena-has-been-granted-us-patent-11912713-titled-7-membered-aza-heterocyclic-containing-delta-opioid-receptor-modulating-compounds-methods-of-using-and-making-for-treating-pain-migraines-depression-parkinsons-disease-and-other-disorders

https://ppubs.uspto.gov/pubwebapp/external.html?q=(11912713).pn

 trevena-inc-announces-4m-concurrent-private-placement-of-2779906-shares-of-common-stock-at-a-price-of-070share-and-warrant-exercise

Trevena Inc. ("Trevena" or the "Company") (NASDAQ:TRVN), a biopharmaceutical company focused on the development...

 why-up-fintech-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket

Shares of UP Fintech Holding Limited (NASDAQ: TIGR) surged in pre-market trading after the company results for the third quarter.

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 recap-trevena-q3-earnings
Recap: Trevena Q3 Earnings
11/14/2023 12:05:21

 trevena-q3-eps-057-misses-015-estimate-sales-18000k-beat-10000k-estimate-cash-and-cash-equivalents-of-35m-is-expected-to-be-sufficient-to-fund-the-companys-operating-expenses-and-capital-expenditure-requirements-into-q3-2024

Trevena (NASDAQ:TRVN) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.15) by ...

 earnings-preview-trevena
Earnings Preview: Trevena
11/13/2023 17:02:20

 why-alteryx-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reporte...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION